Introduction to Coronary Artery Disease (CAD) and Biochemical Markers

作者: Alan H. B. Wu

DOI: 10.1007/978-1-4612-1806-7_1

关键词:

摘要: Cardiovascular disease (CVD) (of which CAD is a subset) the leading cause of morbidity and mortality in Western world. In US, there are approx 70 million people who suffer from one form this or another (Fig. 1) (1). Each year, 500,000 stroke (cerebrovascular accident, CVA). The annual rate CVA about 150,000 individually ranks third overall behind acute myocardial infarction (AMI) (discussed Chapter 3) cancer. Approximately six Americans admitted to hospitals with diagnosis chest pain. Of those individuals CVD, roughly 5% (three million) have silent ischemia. incidence AMI combination patients symptomatic asymptomatic (silent) 1.5 patients/yr. 500,000/yr. Half these deaths occur before they reach hospital for treatment. Unstable angina 2) congestive heart failure (CHF) account large fraction non-AMI A number pain also inappropriately noncardiac causes. remainder discharged home. From group, 30,000 emergency department. 4 discusses impact that cardiac markers on discharge

参考文章(64)
Robin T. Vollmer, Robert H. Christenson, Keith Reimer, E. Magnus Ohman, Temporal creatine kinase curves in acute myocardial infarction. Implications of a good empiric fit with the log-normal function. American Journal of Clinical Pathology. ,vol. 100, pp. 293- 298 ,(1993) , 10.1093/AJCP/100.3.293
The thrombolysis in myocardial infarction (TIMI) trial. The New England Journal of Medicine. ,vol. 313, pp. 1018- ,(1985) , 10.1056/NEJM198510173131611
GRUPPOITALIANOPERLOSTUDIODELL, EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION The Lancet. ,vol. 327, pp. 397- 402 ,(1986) , 10.1016/S0140-6736(86)92368-8
A H Wu, R Valdes, F S Apple, T Gornet, M A Stone, S Mayfield-Stokes, A M Ingersoll-Stroubos, B Wiler, Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction. Clinical Chemistry. ,vol. 40, pp. 900- 907 ,(1994) , 10.1093/CLINCHEM/40.6.900
A H Wu, T G Gornet, J P Bretaudiere, P R Panfili, Comparison of enzyme immunoassay and immunoprecipitation for creatine kinase MB in diagnosis of acute myocardial infarction. Clinical Chemistry. ,vol. 31, pp. 470- 474 ,(1985) , 10.1093/CLINCHEM/31.3.470
M Werner, S H Brooks, R J Mohrbacher, A G Wasserman, Diagnostic performance of enzymes in the discrimination of myocardial infarction. Clinical Chemistry. ,vol. 28, pp. 1297- 1302 ,(1982) , 10.1093/CLINCHEM/28.6.1297
L J Kricka, D Schmerfeld-Pruss, M Senior, D B Goodman, P Kaladas, Interference by human anti-mouse antibody in two-site immunoassays. Clinical Chemistry. ,vol. 36, pp. 892- 894 ,(1990) , 10.1093/CLINCHEM/36.6.892